StockDrifts LogoStockDrifts

Yu Fan 13F Portfolio

Portfolio Manager
Yu Fan
Performance
+17.42% (2026 Q2)
AUM (13F)
$107.92M
# of Holdings
8
Performance Rank
Allocation (Top 20)
99.99%
Latest filing
Q2 2026

Yu Fan Holdings Map

Top 8 Yu Fan Holdings

Top 10 holdings

StockCompany% Port.SharesValueActivityOwnershipAvg. CostDate
KMTS
KESTRA MED TECHNOLOGIES LTD
53.81%2.28M$58.1M
+0.00%(+0)
2025-Q2: 2.28M shares2025-Q3: 2.28M shares2025-Q4: 2.28M shares2026-Q1: 2.28M shares2026-Q2: 2.28M shares
$24.92(+12.44%)
2026-06-30
WHWK
WHITEHAWK THERAPEUTICS INC
20.63%4.86M$22.3M
+134.85%(+2.79M)
2025-Q2: 2.07M shares2025-Q3: 2.07M shares2025-Q4: 2.07M shares2026-Q1: 2.07M shares2026-Q2: 4.86M shares
$3.31(+34.86%)
2026-06-30
ALMS
ALUMIS INC
6.59%252.7K$7.1M
-67.47%(-524.17K)
2025-Q2: 789.6K shares2025-Q3: 789.6K shares2025-Q4: 789.6K shares2026-Q1: 776.8K shares2026-Q2: 252.7K shares
$13.30(+90.30%)
2026-06-30
CBLL
CERIBELL INC
6.17%342.4K$6.7M
-37.68%(-207.05K)
2025-Q2: 1.35M shares2025-Q3: 1.35M shares2025-Q4: 549.4K shares2026-Q1: 549.4K shares2026-Q2: 342.4K shares
$25.22(-7.51%)
2026-06-30
IVA
INVENTIVA SA
5.25%1.50M$5.7M
+0.00%(+0)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 1.50M shares2026-Q1: 1.50M shares2026-Q2: 1.50M shares
$5.22(-11.88%)
2026-06-30
PMN
PROMIS NEUROSCIENCES INC
4.02%329.8K$4.3M
+0.00%(+0)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 329.8K shares2026-Q2: 329.8K shares
$9.76(+52.18%)
2026-06-30
CATX
PERSPECTIVE THERAPEUTICS INC
3.33%1.06M$3.6M
+0.00%(+0)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 1.06M shares2026-Q2: 1.06M shares
$3.46(-7.51%)
2026-06-30
ABTC
AMERICAN BITCOIN CORP.
0.19%308.1K$210K
+0.00%(+0)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 308.1K shares2026-Q2: 308.1K shares
$1.31(+453.35%)
2026-06-30

About Yu Fan’s portfolio

Yu Fan reports $107.92M in US-listed equity holdings across 8 positions in its most recent 13F filing. Its largest disclosed positions are KMTS (53.8%), WHWK (20.6%) and ALMS (6.6%). The top 20 holdings account for 99.99% of reported assets. Its disclosed equity book has returned -43.23% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.

Portfolio concentration

Portfolio concentration
KMTS — 53.8% ($58.07M)WHWK — 20.6% ($22.26M)ALMS — 6.6% ($7.11M)CBLL — 6.2% ($6.66M)IVA — 5.3% ($5.67M)PMN — 4.0% ($4.34M)CATX — 3.3% ($3.60M)ABTC — 0.2% ($209.8K)
100%in top 8
  • KMTS53.8%
  • WHWK20.6%
  • ALMS6.6%
  • CBLL6.2%
  • IVA5.3%
  • PMN4.0%
  • CATX3.3%
  • ABTC0.2%

Portfolio changes

What the fund actually did

Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.

Added to
1
WHWKWHITEHAWK THERAPEUTICS INC+134.8%
Trimmed
2
ALMSALUMIS INC-67.5%
CBLLCERIBELL INC-37.7%

Unlock alerts, watchlists & AI chat

Sign up free to track Yu Fan, compare funds side by side, and get alerts the moment positions change.

Source filings

Holdings on this page are parsed from Yu Fan’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1668029). View Yu Fan’s 13F filings on SEC

More 13F analyses

View all